Bucephalus Grants Options
Toronto, Ontario--(Newsfile Corp. - March 25, 2021) - Bucephalus Capital Corp. (CSE: BCA) ("Bucephalus" or the "Company") announces that it has granted an aggregate of 1,400,000 options to purchase common shares of the Company exercisable at a price of $0.22 per share for a period of 3 years to officers and consultants of the Company. The common shares issuable upon exercise of the options are subject to a four month hold period from the original date of grant.
About Bucephalus Capital Corp.
Bucephalus Capital (CSE: BCA) is a specialized investment firm providing bridge loans and ancillary services to private and public companies with respect to a variety of financial transactions including public listings, RTOs (reverse takeovers), re-structuring and M&A transactions.
Additional information about the Company can be found on the Company's website at www.bucephaluscapital.ca. For further information, please contact:
John McMahon, CEO
Tel: (416) 786-9031
Certain information set forth in this news release may contain forward-looking information that involves substantial known and unknown risks and uncertainties. This forward-looking information is subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, the impact of general economic conditions, industry conditions, and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking information. The parties undertake no obligation to update forward-looking information except as otherwise may be required by applicable securities law.
Neither the Canadian Securities Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/78644